公司資料
Tharimmune 股價、新聞與催化劑
- 股票代碼:
- THAR
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
Current closing-price context is not available for THAR.
公司概覽
業務概覽
Tharimmune is a biotechnology company focused on inflammation, immunology, and specialty therapeutics. Its story centers on a narrow set of programs aimed at difficult immune-mediated conditions.
所在地與產業分類
Tharimmune is headquartered in the United States and listed on NASDAQ. It sits in small-cap immunology biotechnology.
商業模式特徵
The company depends on early-stage clinical and preclinical progress, plus capital efficiency. Investors usually watch data, strategy, and whether the company can sharpen its focus.
生技產業定位
Tharimmune occupies a speculative immunology niche within biotech. It is a catalyst-driven small-cap name where proof-of-concept is essential.
未來催化劑
- Tharimmune’s catalysts are its immune / inflammatory pipeline and any update that shows the company can still keep the story alive. The company remains early and speculative.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。